Latest News and Press Releases
Want to stay updated on the latest news?
-
Communiqué de Presse Atos annonce la nomination de Marie de Scorbiac au poste de Directrice des Relations Investisseurs et de la RSE Paris, France – 28 avril 2025 – Le groupe Atos annonce...
-
Press Release Atos announces the appointment of Marie de Scorbiac as Head of Investor Relations and CSR Paris, France – April 28, 2025 – Atos Group today announces the appointment of Marie de...
-
LOS ANGELES, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Transom Capital Group (“Transom”) has named Dana Goldstein to the newly created position of Head of Investor Relations and Marketing, where she will...
-
FactSet and Irwin announced a strategic partnership integrating Irwin’s award-winning investor relations CRM with FactSet’s Workstation.
-
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and...
-
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 19, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential biodata life science partner for rare and...
-
Enables refocusing on core business of delivering valuable, data-driven insights to patients, and pharmaceutical companies globallyEUR 15 million private placement from leading growth investors and a...
-
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose,...
-
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose,...
-
Company outlines significant value creation potential to contribute to the diagnosis of rare diseases and to enable the development of novel therapeuticsFocuses on leveraging its unique rare...